Open AccessBenefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation
Author(s) -
David M. Mannino,
Michael Bogart,
Guillaume Germain,
Shengming Huang,
Afisi S Ismaila,
François Laliberté,
Young Yun Jung,
Sean D. MacKnight,
Marjorie Stiegler,
Mei Sheng Duh
Publication year - 2022
Publication title -
international journal of chronic obstructive pulmonary disease/international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s337668
Subject(s) - medicine , fluticasone propionate , exacerbation , copd , corticosteroid